We are live on ! Find out more
PODD icon

Insulet

467 hedge funds and large institutions have $16.3B invested in Insulet in 2022 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 167 increasing their positions, 161 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 36

4% more funds holding

Funds holding: 449467 (+18)

5% more capital invested

Capital invested by funds: $15.6B → $16.3B (+$725M)

4% more repeat investments, than reductions

Existing positions increased: 167 | Existing positions reduced: 161

0.72% less ownership

Funds ownership: 103.31%102.59% (-0.72%)

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

40% less call options, than puts

Call options by funds: $36.6M | Put options by funds: $61.1M

Holders
467
Holders Change
+18
Holders Change %
+4.01%
% of All Funds
8.04%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
56
Increased
167
Reduced
161
Closed
36
Calls
$36.6M
Puts
$61.1M
Net Calls
-$24.5M
Net Calls Change
-$14.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$2.38B -$739K -2,952 -0%
Capital Research Global Investors
2
Capital Research Global Investors
California
$1.48B -$72M -287,549 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.47B +$16.2M +64,742 +1%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$1.16B -$25.7M -102,807 -2%
BlackRock
5
BlackRock
New York
$1.1B +$17.7M +70,523 +1%
Capital World Investors
6
Capital World Investors
California
$951M -$11M -43,785 -1%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$749M -$50.8M -203,015 -6%
ClearBridge Investments
8
ClearBridge Investments
New York
$381M -$1.16M -4,636 -0.3%
JP Morgan Chase
9
JP Morgan Chase
New York
$336M +$7.04M +28,117 +2%
State Street
10
State Street
Massachusetts
$330M +$2.99M +11,946 +0.8%
DCP
11
D1 Capital Partners
New York
$305M +$23.1M +92,376 +7%
Primecap Management
12
Primecap Management
California
$269M -$2.25M -8,990 -0.8%
Ameriprise
13
Ameriprise
Minnesota
$233M -$39.8M -159,001 -14%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$212M +$3.54M +14,135 +2%
Invesco
15
Invesco
Georgia
$163M +$6.06M +24,186 +4%
Goldman Sachs
16
Goldman Sachs
New York
$153M +$13M +51,763 +8%
FAM
17
Fred Alger Management
New York
$145M +$2.58M +10,308 +2%
Morgan Stanley
18
Morgan Stanley
New York
$143M -$653K -2,607 -0.4%
Viking Global Investors
19
Viking Global Investors
Connecticut
$140M +$27M +107,637 +21%
Franklin Resources
20
Franklin Resources
California
$134M +$1.92M +7,661 +1%
Bank of America
21
Bank of America
North Carolina
$128M -$7.48M -29,856 -5%
Allspring Global Investments
22
Allspring Global Investments
North Carolina
$123M -$8.42M -33,607 -6%
RSCM
23
Rock Springs Capital Management
Maryland
$119M +$4.13M +16,500 +3%
William Blair Investment Management
24
William Blair Investment Management
Illinois
$115M +$108K +432 +0.1%
ESCM
25
Echo Street Capital Management
New York
$114M -$78.3M -312,737 -39%

PODD Hedge Fund Activity: Q3 2022 in Review

467 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2022, worth a combined $16.3B — up 4.6% from $15.6B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new PODD positions and 36 closed out — a net gain of 20 holders — while 167 added to existing stakes and 161 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $64.9M. The largest seller was Marshall Wace, cutting an estimated $108M.

  • 467 institutional investors held Insulet (PODD) as of Q3 2022, up from 449 in Q2 2022.
  • Funds reported $16.3B of Insulet stock for Q3 2022, up 4.6% quarter-over-quarter.
  • 56 funds opened new Insulet positions in Q3 2022 and 36 closed out, a net change of +20 holders.
  • The largest Insulet buyer in Q3 2022 was Lord, Abbett & Co, an estimated $64.9M added.
  • The largest Insulet seller in Q3 2022 was Marshall Wace, an estimated $108M sold.

Based on aggregated 13F filings for Q3 2022.